Compare CADL & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CADL | VBNK |
|---|---|---|
| Founded | 1999 | 1980 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.7M | 606.0M |
| IPO Year | 2021 | 2016 |
| Metric | CADL | VBNK |
|---|---|---|
| Price | $8.88 | $17.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $19.00 | $13.00 |
| AVG Volume (30 Days) | ★ 2.2M | 83.1K |
| Earning Date | 05-14-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 0.41% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | $30.02 |
| Revenue Next Year | N/A | $27.30 |
| P/E Ratio | ★ N/A | $25.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.35 | $10.10 |
| 52 Week High | $9.26 | $19.02 |
| Indicator | CADL | VBNK |
|---|---|---|
| Relative Strength Index (RSI) | 75.99 | 50.24 |
| Support Level | $4.80 | $15.74 |
| Resistance Level | N/A | $17.42 |
| Average True Range (ATR) | 0.52 | 0.53 |
| MACD | 0.18 | -0.15 |
| Stochastic Oscillator | 84.41 | 17.21 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.